专题：Safe Handling of Antineoplastic Drugs

This cluster of papers focuses on the occupational exposure of health care workers to antineoplastic drugs, highlighting issues such as surface contamination, biological and environmental monitoring, use of closed-system protective devices, and the assessment of genotoxic effects. The papers also discuss the adherence to safety guidelines and the impact on reproductive health. The research aims to improve practices and reduce risks associated with handling antineoplastic drugs in healthcare settings.
最新文献
Vision 2035 – Medico-Pharmaceutical Law for Human Security

book Full Text OpenAlex

Extemporaneous Formulations for Pediatric Patients: Global Necessities, Challenges and Opportunities

article Full Text OpenAlex

Do we worry too much about polysorbate degradation? An industry-wide perspective with real-life case studies

article Full Text OpenAlex

European Code Against Cancer, 5th edition – occupational exposures and cancer

article Full Text OpenAlex

Analysis of the formation of (sub)visual particles in ready-to-administer trastuzumab infusion bags during transport from the hospital pharmacy to patients at home

article Full Text OpenAlex

Carbon footprint of total intravenous anaesthesia vs. inhalational sevoflurane anaesthesia in adults

article Full Text OpenAlex

Impact of an autonomous delivery robot on sample turnaround time in a clinical laboratory: an early evaluation of first implementation

article Full Text OpenAlex

Pharmaceutical consultation on patients receiving oral antineoplastic agents: a systematic review

review Full Text OpenAlex

Assessing the Influence of a Statewide Dosing Reference Aid on Prehospital Pediatric Medication Dosing Errors: A Mixed-Methods Simulation-Based Investigation

article Full Text OpenAlex

Audit des conditions de stockage des dispositifs médicaux implantables dans les services de soins

article Full Text OpenAlex

近5年高被引文献
Management of Immunotherapy-Related Toxicities, Version 1.2022, NCCN Clinical Practice Guidelines in Oncology

review Full Text OpenAlex 399 FWCI39.1453

Three-Year Update of Tisagenlecleucel in Pediatric and Young Adult Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia in the ELIANA Trial

article Full Text OpenAlex 323 FWCI30.764

Variable vs. Fixed Dosing of Monoclonal Antibodies in Oncology

preprint Full Text OpenAlex 158 FWCI0

Socioeconomic and Racial Disparity in Chimeric Antigen Receptor T Cell Therapy Access

article Full Text OpenAlex 132 FWCI12.5597

Mesothelin-targeting T cell receptor fusion construct cell therapy in refractory solid tumors: phase 1/2 trial interim results

article Full Text OpenAlex 92 FWCI21.4577

Resisting disinfectants

article Full Text OpenAlex 72 FWCI9.3804

The Advent of a New Era in Digital Healthcare: A Role for 3D Printing Technologies in Drug Manufacturing?

review Full Text OpenAlex 70 FWCI5.4573

ISOPP Standards for the Safe Handling of Cytotoxics

article Full Text OpenAlex 61 FWCI29.5851

Consensus guidelines and recommendations for the management and response assessment of chimeric antigen receptor T-cell therapy in clinical practice for relapsed and refractory multiple myeloma: a report from the International Myeloma Working Group Immunotherapy Committee

review Full Text OpenAlex 55 FWCI15.957

Antimicrobial Preservatives for Protein and Peptide Formulations: An Overview

review Full Text OpenAlex 50 FWCI7.8253